chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling in right arm from site of injection down to and including fingers and up to right side of face. Also some redness in upper arm and shoulder. Ibuprofen500mg taken and ice applied for inflammation and pain. Lasting 48 hours.
Redness, swelling, hard lump at injection site, warmth around injection site, soreness, itching.
Systemic: Seizure-Mild, Additional Details: Patient suffered a seizure about 10 minutes after vaccine administration. She came out of the seizure as she was being brought to the floor from the chair. She was able to explain that she has suffered from seizure in the past. She was taken to the hospital by EMTs.
Pt reports she developed swelling that evening after Johnson & Johnson Covid vaccine.  Reported on 11/30 during ED visit for unrelated reasons.
Fatigued; Rash on her arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE and VACCINATION SITE RASH in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03A221A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced FATIGUE and VACCINATION SITE RASH. At the time of the report, FATIGUE and VACCINATION SITE RASH outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.   This case was linked to MOD-2021-068362, MOD-2021-068362.   Most recent FOLLOW-UP information incorporated above On 17-May-2021: Follow up received on 17-may-2021 content non significant information.
Ventricular tachycardia with a pulse.  Cardioversion x 3, Amiodarone 300mg IVP, Lidocaine 100mg IVP, Amiodarone drip & Levophed drip started.
Pt vaccinated with DTP/OPV/HIB developed red splotchy circles on rt side of face; Hives on abd. Taken by w/c  to Hlth Ctr no wheezing; no apparent distress. Evaluated by MD - chest clear, DX hives s/p immunization.
Approximately 1 week post immunization (ZOSTAVAX) pt developed rash over entire body. Pt saw PCP and was treated w/rx meds. Pt report no fever.
none; Nurse mgr/ APRN at the Health Dept. discovered that the above mentioned Pfizer vaccine was not properly removed from the regular freezer (-25 degrees c to -15 degrees c) on 10/13/2021.  The Pfizer vaccine was moved ultra cold freezer to regular freezer on 09/28/21 and should have been removed from the regular freezer the end of the day on 10/13/21 and placed in the refrigerator for 31 days. The vaccine was not removed on this day the freezer. The vaccine is still in the freezer today 10/25/21. It was investigated and found that the vaccine was use in clinic Monday 10/18 through 10/23. NP called Pfizer medand spoke c an attendant, walked her through the scenario and she made NP aware that vaccine could not be used past day 17 after being in the regular freezer, voice that vaccine stability could not be determined and that vaccine should not have been used past the 3 day grace or day 17 and should have been moved to the refrigerator on day 14 after removed from regular freezer. Patient was notified of the incident.                                                                                                                                             FNPC                                                                                                                                           Nurse Manager                                                                                                                                           Health Dept.
Patient developed a stiff neck on the night his vaccine was given. 1/28/16 - 1/29/16 (no fever).
About a month after the initial vaccine, I experienced increased inflammation in my body (i,e., more headaches, joint aches, low back aches). I also had neurological sensations - burning soles of the feet and palms of the hands. Some mornings when I woke up my calves burned.
pt began screaming inconsolably about 4PM, rt hip swollen, red & warm (swollen fr bottom of diaper to top of knee); approx 5 mins later both feet became swollen, red & hot & lt calf; t103 ax, bad cough, swelling around rt eye;
Periodic minor chest pain.  Started approximately 10 days post vaccination.  Persisted for approximately 9 weeks.
Rash on neck and shoulders; This is a spontaneous report from a contactable other health professional (patient). A 24-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via intramuscular route of administration, administered in Arm Right on 05Jan2021 14:00 (at the age of 24 years old) as dose number unknown, single for COVID-19 immunisation at nursing home. Medical history included COVID-19 from an unknown date and unknown if ongoing (COVID prior vaccination: Yes). Concomitant medications within two weeks included birth control. Patient did not received other vaccine within four weeks of COVID vaccine. Patient have COVID prior to vaccination. The patient experienced rash on neck and shoulders on 2021. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Patient tested for COVID post vaccination. The patient underwent lab tests and procedures which included sars-cov-2 test: unknown on 2021. Outcome of the event was unknown.  Follow-up attempts completed. No further information expected.
March 9, started experiencing upper respiratory infections with heavy green mucus and sore throat. Was diagnosed with tonsillitis and I have been having multiple flare ups. Went to ENT and have been on multiple rounds of antibiotics. At one point I had severe bleeding from tonsils. I have never had tonsillitis issues prior to the 3 dose of Moderna Vaccine.
Bells Palsy on right side of my face; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 56-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 01Apr2021 14:30 (at the age of 56-years-old) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had known allergies to Penicillin. No other vaccine in four weeks. No other medications in two weeks. No COVID prior vaccination. No COVID tested post vaccination. On 07Apr2021, the patient experienced bell's palsy on right side of my face. The patient visited to physician office for the adverse event. The patient received unspecified steroids as treatment for adverse event. The patient received her second dose of vaccine on 22Apr2021. The outcome of the event was recovered on an unspecified date in 2021.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Tiredness Low energy Headache Sensitive to light Body ache Muscle ache Chills Fever Nausea No appetite
Red, swollen 9 1/2 cm x 5 1/2 cm.
Swelling, redness, itching, soreness, firmness Today is day 7 and all symptoms have subsided, but still there. They are now mild and don't affect activities of daily living.
The following day of the shot, I had a very heavy flow with very bad cramping. I had a headache, but I think that was a result of the vaccine so that was kind of normal. My period was extremely heavy and my period was on time, but it was too painful and cramping. I also felt really dizzy that it felt like I was losing too much blood. I did not see a doctor, but I did speak to him on my physical which it was 10/01/2021. He said he didn't notice any major issues. I don't know if he even noted that on my chart.
Redness, swelling and warmth at the injection site in deltoid and a larger area between the injection site and the elbow of the same arm.
Information has been received from a physician concerning a 15 year old female patient who on approximately 11-JUN-2010 ("either the end of last week 07-JUN-2010 or in the beginning of this week 14-JUN-2010") was vaccinated with the first dose of GARDASIL (lot# not reported). On approximately 11-JUN-2010, immediately after receiving the first dose of GARDASIL, the patient began to seize, but the seizing resolved almost immediately as well. Unspecified medical attention was sought. The physician reported that the patient recovered the day she received the first dose of GARDASIL. Upon internal review, seize was considered to be an other important medical event. Additional information has been requested.
knot in left armpit, mucus drainage, sneezing, 2 weeks, fatigue, headaches, chest pains,
(6) days after 1st injection (Tues. 1/19) mom began having acute pain on right side, right breast area, under right arm, and also right side of back.  She initially thought she may have pulled a muscle.  Mom is very active for her age.  On Saturday (1/23) pain became unbearable and we went to her home.  My wife looked at the areas where pain was occurring and saw rash that looked like shingles. Mom was taken to urgent care and shingles was confirmed and Gabapentin was prescribed.  Numerous pain medication and other medications later the pain has not eased.
Sore throat, diarrhea (one event), vomiting (once), mild fever (99.6), loss of appetite. Almost recovered by bedtime. Completely recovered by next morning.
Pt vaccinated with DTP/OPV experienced cough, temp, screaming, diarrhea, rash, probably flu, asthma or allergic reactions, fussy, flushed,and screaming. See WORM for all details.
Patient received vaccine at 11:55am and reported hives and itching at 12:00pm. Had Benadryl 50mg IM administered at 12:10pm and symptoms improved after administration.
adult dose to pediatric patient; adult dose to pediatric patient; This case was reported by a nurse via sales rep and described the occurrence of overdose in a patient who received HAV (Havrix adult) for prophylaxis.   On an unknown date, the patient received Havrix adult. On an unknown date, unknown after receiving Havrix adult, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter reported a mal administration of adult dose to pediatric patient, which led to overdose and adult product administered to child. The reporter did not agree to follow up from GlaxoSmithKline.
Initial information received on 18-Jul-2018 regarding an unsolicited valid non-serious case received from a non-health professional. This case involves a 13 months old male patient who experienced fever, had severe right rash after receiving PENTACEL, swelling, fussiness and banging head, joint pain, screaming and has skin lesions that are tender on right thigh, while he received vaccine PENTACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 03-Jul-2018, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5)/HIB (PRP/T) VACCINE (lot number: C5437AA) (expiry date, dose, dose in series, route and site of administration were not reported). On an unknown date, the patient developed a non-serious fever following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5)/HIB (PRP/T) VACCINE. On an unknown date, the patient developed a non-serious had severe right rash after receiving PENTACEL following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5)/HIB (PRP/T) VACCINE. On an unknown date, the patient developed a non-serious swelling following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5)/HIB (PRP/T) VACCINE. On an unknown date, the patient developed a non-serious fussiness, banging head following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5)/HIB (PRP/T) VACCINE. On an unknown date, the patient developed a non-serious joint pain following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5)/HIB (PRP/T) VACCINE. On an unknown date, the patient developed a non-serious screaming following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5)/HIB (PRP/T) VACCINE. On an unknown date, the patient developed a non-serious has skin lesions that are tender on right thigh following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5)/HIB (PRP/T) VACCINE. Other relevant tests included No lab data was reported. Final diagnosis was has skin lesions that are tender on right thigh, screaming, joint pain, fussiness and banging head, swelling, had severe right rash after receiving PENTACEL and fever. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for fever, as Unknown for had severe right rash after receiving PENTACEL, as Unknown for swelling, as Unknown for fussiness and banging head, as Unknown for joint pain, as Unknown for screaming and as Unknown for has skin lesions that are tender on right thigh. List of documents held by the sender: None.
Menstrual cycle was very irregular. After the first vaccine my period started 2 weeks sooner than normal with excess bleeding and cramps. Then my next period started over 50 days later, which is about one to two weeks later than normal. Now I have not had a period in over 70 days and I?m suspicious the vaccine has caused irregularities. I am further concerned this will impact my fertility, given I need a period in order to ovulate.
Red, swollen & painful at the sites of the injections, feverish, aches, chills, pain in axilla & shoulder. Pt was prescribed Naproxen sodium 220 mg, BENADRYL 25 mg.
Ringing in left ear with decreased hearing.  Feels like pulsating in ear intermittently. Other times it?s just ringing or whirling sensation.   Have not seen provider yet for symptoms/adverse reaction.
pt recvd vax; on 22oct starting running t 106; rash; to MD on 26oct;
patient came to pharmacy in person for a injection site reaction check. patient states the deltoid region of her upper left arm has been painful, red and hot to the touch since recieving her HD flu shot on 10/21/2020.  Upon inspection of the region I did not notice any redness or swelling and patient had good range of motion with her arm.  It was however hot to the touch.  Pt states the condition is getting better each day.  I counseled her on injection site reactions and how this may even be a mild allergic reaction.  She does not report any trouble breathing/shortness of breath or swelling in any other regions of her body.  I will follow up with VARS reporting.
Malaise; Flu; Hotness/heat; Back pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Malaise), INFLUENZA (Flu), FEELING HOT (Hotness/heat) and BACK PAIN (Back pain) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Malaise), INFLUENZA (Flu), FEELING HOT (Hotness/heat) and BACK PAIN (Back pain). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, MALAISE (Malaise), INFLUENZA (Flu), FEELING HOT (Hotness/heat) and BACK PAIN (Back pain) outcome was unknown.            No concomitant medications were mentioned. It was reported that patient had sometimes experienced the same symptoms, because of the changing weather.
Fatigue experienced a couple hours after injection and lasted about 12 hours.  Pain in injection site and muscle (thigh) felt about 30 minutes afterwards and lasted for a few days. Body aches and chills started 10 hours after injection (11:30pm). Chills lasted until patient went to sleep around 12:30/1am. Body aches continued into next evening but went away by Tuesday morning.
Injection site pain; Neck muscle soreness; Shoulder soreness; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced injection site pain (Verbatim: Injection site pain), muscle soreness (Verbatim: Neck muscle soreness) and shoulder soreness (Verbatim: Shoulder soreness).  The outcome of the injection site pain, muscle soreness and shoulder soreness were not reported.   It was unknown if the reporter considered the injection site pain, muscle soreness and shoulder soreness to be related to Arexvy.     It was unknown if the company considered the injection site pain, muscle soreness and shoulder soreness to be related to Arexvy.   Additional Information: GSK Receipt date: 28-SEP-2023 This case was reported by patient via interactive digital media. It was reported that patient experienced injection site pain, neck muscle soreness and shoulder soreness after receiving Arexvy vaccine. Follow up was not possible, as no contact details were available.
swelling of arm under vaccination site, headache, fever, fatigue, joint pain, chills, dry heave cough, body aches, taste off
Initial unsolicited report received from consumer on 05 MAY 2015. An 80-year-old female patient had received a dose of INFLUENZA (batch number, expiration date, dose, dose cycle, route and site of administration were not reported) on an unspecified date in 2015. The patient medical history reported as TMJ Syndrome, obsessive-compulsive disorder, depression, anxiety, no sex in fifteen years which was still ongoing and previous medication includes 0.625 mg cream of PREMARIN (batch number: J87776, expiration date: MAY 2016, indication: vaginal dryness) squeeze from tube onto finger nightly before bed and PROZAC for depression. PAXIL, LORAZEPAM and antihypertensives and also CLONAZEPAM. The patient had also received an unknown name product medication which had an applicator as well. On an unspecified date in 2015, after vaccination patient had experienced a pain which was so bad, feeling really bad, disoriented and panic attack. Laboratory investigation includes unspecified test performed by gynecologist on an unspecified date, result reported as vaginal dryness. Corrective treatment was not reported. At the time of this report, outcome of the event was unknown. List of the documents held by sender: none.
Developed positive Covid-19:  symptoms developed on 3/29/2021, test results on 4/1/2021
My initial dose was on a Sunday evening. By Tuesday morning, my right arm was slightly sore and a bit red but gone by the next day. On the 8th day, my right arm was very itchy, large red welt, sore to touch and warm. The welt grew bigger for 3 days and itching and soreness increased. By the 4th day, itching and soreness began to subside. By the 5th day, the redness began to go away. 2nd dose scheduled for 1/24/21
This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), SINUSITIS (Sinus infection), ARTHRALGIA (Shoulder pain) and FEELING ABNORMAL (Foggy feeling in head) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Psoriatic plaque.    No Medical History information was reported.   On 30-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced COVID-19 (COVID-19), SINUSITIS (Sinus infection), ARTHRALGIA (Shoulder pain) and FEELING ABNORMAL (Foggy feeling in head). At the time of the report, COVID-19 (COVID-19) and SINUSITIS (Sinus infection) was resolving, ARTHRALGIA (Shoulder pain) had resolved and FEELING ABNORMAL (Foggy feeling in head) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No concomitant or treatment medication provided
I started to develop hives on my under arm and as time passed the hives appeared on my neck, chest, stomach, and back. I have been taking Benadryl but that does not seem to be helping with the itch.
Student's father refers the day after Flu Mist was given, she developed a severe allergic reaction (Lips and hands were swollen and had breathing difficulties). Parents took student to a Clinic to get treatment.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medications were not reported. On 16-JAN-2019, the patient was vaccinated with VARIVAX (strength, dose, frequency, route, lot # and expiry were not reported) for prophylaxis, reconstituted with expired sterile diluent (strength, dose, frequency were not reported) lot # M019891 and expiry date reported 11-OCT-2018 and no adverse effects were reported. This is one of the 3 reports concerning same reporter.
This spontaneous report was received from a medical assistant referring to a multiple patients of unknown age and gender. These patients' concomitant medication, pertinent medical history and drug reactions were not reported. On unspecified dates since 21-JUL-2017, these patients were administered improperly stored RECOMBIVAX HB (lot# M028322 with expiration date 31-MAY-2019, lot# M041384 with expiration date 07-JUL-2019, lot# N005996 with expiration date 07-JUL-2019, dose and route not reported) for prophylaxis. The vaccine was exposed to temperature excursion of 47 to 77 Fahrenheit (F) for 43 minutes. There was no previous temperature excursion. The data logger was involved. No adverse effect was reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA004623: US-009507513-1708USA007735: US-009507513-1709USA004622: US-009507513-1709USA004619: US-009507513-1709USA004620.
4/10/21 - spotted after getting the vaccine (period) and shoulder muscle where the shot was given  was very tender and hot to the touch.  4/10/21 - started period 1 week early, heavier than normal. (This is not something that happens to me.)  Also felt sick which included mild sore throat, head ache, easily sweating or cold, and had fatigue. Symptoms are improved but lingering today, 4/12/21.